The Effectiveness of Medicines in Containing Health Care Costs: Impact of Innovation, Regulation and Quality : Proceedings [of] a Symposium and Workshop |
Contents
241 | 3 |
Review of the Literature and Public Policy Proposals Ronald W Hansen Ph D 53 | 75 |
A Study of the Effects of Formulary Limitations in Medicaid Drug Programs | 117 |
Copyright | |
2 other sections not shown
Common terms and phrases
administrative costs American Enterprise Institute analgesics analysis associated average changes chlordiazepoxide cimetidine clinical competition cost of illness cost-effectiveness decline dependent variable disease dollars drug costs drug industry drug prices drug products drug program drug therapy economic effective patent estimated evaluation factors firms formulary restrictions Grabowski HCFA higher hospital impact implementation incentive increase incremental indirect costs innovation introduction investment JACK MEYER MAC drugs MAC Group MAC limits MAC price MAC pro MAC program maceutical market share Medicaid drug Medicaid program million outlays overall participation rate Peltzman percent period pertussis Ph.D phar pharmaceutical industry pharmacists Pharmacy physicians Pracon problem profitability Project HOPE promotion Public Policy question reduced regression regulations regulatory reimbursement research and development restrictive formulary savings significant substitution laws Table testing tion vaccine Wardell Weisbrod Weston William Wardell